The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The role of androgen response pathway in association with tumor biology and response to neoadjuvant immune-checkpoint inhibitors (ICI) in muscle-invasive urothelial bladder carcinoma (MIBC).
 
Valentina Tateo
No Relationships to Disclose
 
Ewan Gibb
Employment - Decipher Biosciences; Veracyte
 
Chiara Mercinelli
No Relationships to Disclose
 
Daniele Raggi
No Relationships to Disclose
 
Antonio Cigliola
No Relationships to Disclose
 
Damiano Alfio Patanè
No Relationships to Disclose
 
Emanuele Crupi
No Relationships to Disclose
 
Patrizia Giannatempo
Honoraria - Astellas Pharma; Gilead Sciences; Janssen medical Affairs; Pfizer
Consulting or Advisory Role - Astellas Pharma; Gilead Sciences; Janssen Oncology; Merck; Pfizer
Research Funding - AstraZeneca; Ipsen; MSD Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Roche; Bristol-Myers Squibb/Roche; Pfizer
 
Maurizio Colecchia
No Relationships to Disclose
 
Marco Moschini
No Relationships to Disclose
 
Giulio Avesani
No Relationships to Disclose
 
Alberto Briganti
No Relationships to Disclose
 
Francesco Montorsi
No Relationships to Disclose
 
Daniele Santini
No Relationships to Disclose
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Foundation Medicine; Janssen; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; Bayer; Bristol-Myers Squibb; Catalym; Clovis Oncology; GlaxoSmithKline; Incyte; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Gilead Sciences; Ipsen; Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Sharp & Dohme; Pfizer; Rainier Therapeutics; Roche
Other Relationship - Bayer (I)